Navigation Links
AMT Announces Management Changes in Light of Refocused Strategy
Date:12/2/2009

AMSTERDAM, December 2 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today a number of management changes. Piers Morgan (age 43) has been appointed Chief Financial Officer, effective December 1, 2009. Hans Preusting, PhD (age 47), Director Process Development & Manufacturing, will take up the responsibility for Operations and Project Management, also effective December 1. These changes reflect the refocused strategy of the company announced in the third quarter update on 18 November 2009.

In addition to the anticipated filing for regulatory approval of its lead product Glybera(R), a gene therapy product to control LipoProtein Lipase Deficiency (LPLD), AMT is focusing on accelerating the development of 4 of its pipeline products, using its stable and scalable AAV (adeno-associated viral vector) production platform. These projects are Hemophilia B, Duchenne Muscular Dystrophy, Acute Intermittent Porphyria and Parkinson's Disease. Furthermore AMT is implementing a business model combining proprietary and partnered development of these products in order to retain value and conserve cash.

Piers Morgan is a University of Cambridge graduate (MA in Law and Management Studies), who received his ACA Qualification while at PriceWaterhouseCoopers, and who worked in M&A advisory with Close Brothers Corporate Finance and Ernst & Young before starting his career in biotechnology. He was Finance Director for Arrow Therapeutics where he successfully raised equity and debt capital, became CFO of BioAlliance Pharma SA in Paris, France, where he led the company's IPO on Euronext, and recently was CFO and CBO at Phytopharm plc in the UK. He will succeed Andre Verwei, who was as AMT's CFO as from 2005.

Before joining AMT in 2006, Hans Preusting had more than 14 years of experience in the production process of biologic
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... HILL, N.C. , Dec. 19, 2014 /PRNewswire/ ... to optimize a product,s web presence to reflect ... Brand websites, in particular, must meet the needs ... regulations and culture. According to ... more than half of the participating companies averaged ...
(Date:12/19/2014)... Dec. 19, 2014  Monarch America Inc. (OTCQB: CANK) ... is pleased to provide this review of the Company,s ... 2015. "Over this past year, we achieved ... am extremely proud to say that Monarch America is ... it has ever been," stated Eric Hagen , ...
(Date:12/19/2014)... WORTH, Texas , December 18, 2014 /PRNewswire/ ... a networked software application/module that is used to ... related images. RIS comprises a patient tracking and ... system. The integration of RIS with HIS and ... used for patient registration and patient scheduling, patient ...
Breaking Medicine Technology:Building a Best-in-Class Pharma Global Brand Website 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... For Judith Talnadge, a power wheelchair provided through Medicare ... with opportunities to visit with friends and engage in ... Those starkly different living environments are ... who suffers from muscular dystrophy and spina bifida.  These ...
... Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) today announced its ... Optimer reported net income for the first quarter of 2011 of ... respectively, as compared to a net loss for the first quarter ... a basic and diluted basis.  The increase in net income was ...
Cached Medicine Technology:Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence 2Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence 3Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence 4Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results 2Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results 3Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results 4Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results 5Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results 6
(Date:12/20/2014)... December 20, 2014 DePuy Pinnacle ... metal-on-metal version of the artificial hip system was ... and federal courts, Bernstein Liebhard LLP reports. According ... County Superior Court on December 2nd, counsel in ... deposition of plaintiffs on November 19, 2014, with ...
(Date:12/20/2014)... December 20, 2014 Recently, VogueQueen.com, a ... VogueQueen Big Sale Online for 2015. Great ... All new and old consumers can get a discount, ... at the company’s website before January 30, 2015. , ... dresses and launched a prom dress promotion. Many customers ...
(Date:12/20/2014)... York, New York (PRWEB) December 20, 2014 ... continue to move forward in U.S. courts, ... new study which suggests that children treated with ... a hormone linked to breast development and lactation. ... looked at 34 children and adolescents who began ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer (called ... Christmas. In the promotion, all buyers worldwide can enjoy ... something special for the women who are looking for ... new collections of 2015 dresses have been unveiled recently. ... discounted prices. Visit our website now before they are ...
(Date:12/20/2014)... Twin Cities DI Day is recognized as the premier ... financial professionals come together each year to hear up ... to protect their clients and to be inspired by ... of disability. , On September 23rd, 2014, financial professionals ... The 13th Annual Twin Cities DI Day where they ...
Breaking Medicine News(10 mins):Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3
... 31 The following,is being released by the Campaign ... from across New Jersey express strong support,for 100 percent ... to 28 percent), voters support extending the statewide Smoke-Free,Air ... from a,broad-based coalition of voters across the state, including ...
... data finds no link to most common illnesses , ... do not increase the risk of cancers, connective tissue ... researchers. , A team from the International Epidemiology Institute ... in Nashville, Tenn., reviewed available research on the safety ...
... 31, 2007 A new study appearing in International ... anti-cancer agent that prevents tumor growth by interfering with ... potential to improve the efficacy of standard combination chemotherapy ... most common cancer in women, accounting for nearly 14,000 ...
... month of November,American Diabetes Month, the Erectile Dysfunction ... (ED) to ask,their doctor about being screened for ... under-discussed complication of,diabetes," states Dr. Ananda Basu, an ... don,t realize is that coronary heart disease,is the ...
... LAKE FOREST, Ill, Oct. 31 Hospira, Inc.,(NYSE: ... today,that Thomas E. Werner, senior vice president, Finance, and ... Credit Suisse Phoenix,Health Care Conference on Tuesday, Nov. 13, ... to all interested parties at noon,Mountain Time on Tuesday, ...
... wellness ... options, CAMP HILL, ... linked to lifestyle. In fact, half of the two,million premature deaths that ... poor nutrition, and lack of,exercise -- are a primary reason for rising ...
Cached Medicine News:Health News:New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos 2Health News:New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos 3Health News:Little Evidence Silicone Breast Implants Harm Health 2Health News:Diabetic Men With Erectile Dysfunction Urged to Consult Their Doctors During November - American Diabetes Month 2Health News:Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13 2Health News:Highmark Blue Shield Program Rewards Members for Enhancing their 'Healthstyle' 2Health News:Highmark Blue Shield Program Rewards Members for Enhancing their 'Healthstyle' 3
This high technology cast plaster cutter saw is very easy and comfortable to use....
... a minimum results in less emotional trauma ... the clinician. The innovative motor plus saw ... lighter package. In addition, the unique design ... more user comfort. Plus automated multi-speed controls ...
The True/Fix Cannulated Bone Screw System contains 7.0mm large cannulated bone screws and 3.5mm cortical and 4.0mm cannulated cancellous bone screws....
LEMAIRE stapes are stainless steel staples indicated for ligament fixation....
Medicine Products: